• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯哌嗪衍生物作为肠道渗透增强剂的结构-功能分析。

Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.

机构信息

Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.

Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, 15213, USA.

出版信息

Pharm Res. 2017 Jun;34(6):1320-1329. doi: 10.1007/s11095-017-2149-8. Epub 2017 Apr 3.

DOI:10.1007/s11095-017-2149-8
PMID:28374339
Abstract

PURPOSE

A major obstacle preventing oral administration of macromolecular therapeutics is poor absorption across the intestinal epithelium into the bloodstream. One strategy to improve transport across this barrier is the use of chemical permeation enhancers. Several molecular families with permeation enhancing potential have been identified previously, including piperazines. In particular, 1-phenylpiperazine has been shown to enhance transepithelial transport with minimal cytotoxicity compared to similarly effective molecules. To better understand how the chemistry of 1-phenylpiperazine affects its utility as an intestinal permeation enhancer, this study examined a small library of 13 derivatives of 1-phenylpiperazine.

METHODS

The efficacy and cytotoxicity of 13 phenylpiperazine compounds were assessed in a Caco-2 model of the intestinal epithelium. Efficacy was measured using the paracellular diffusion marker calcein as well as by immunostaining and confocal imaging of Caco-2 monolayers.

RESULTS

Of the 13 derivatives, two enhanced the permeability of the fluorescent marker calcein over 100-fold. It was found that hydroxyl or primary amine substitutions on the phenyl ring significantly increased toxicity, while aliphatic substitutions resulted in efficacy and toxicity profiles comparable to 1-phenylpiperazine.

CONCLUSIONS

Several potent derivatives, including 1-methyl-4-phenylpiperazine and 1-(4-methylphenyl)piperazine, displayed lower toxicity than 1-phenylpiperazine, suggesting promise in future applications.

摘要

目的

阻止大分子治疗药物经口服进入血液循环的主要障碍是肠道上皮细胞的吸收不良。提高这种屏障通透性的一种策略是使用化学渗透增强剂。先前已经确定了几个具有渗透增强潜力的分子家族,包括哌嗪。特别是,与同样有效的分子相比,1-苯基哌嗪已被证明可在最小细胞毒性的情况下增强跨上皮转运。为了更好地了解 1-苯基哌嗪的化学性质如何影响其作为肠道渗透增强剂的用途,本研究研究了 1-苯基哌嗪的 13 种衍生物的一个小文库。

方法

在肠上皮细胞的 Caco-2 模型中评估了 13 种苯哌嗪化合物的功效和细胞毒性。功效通过使用细胞旁扩散标记物 calcein 以及通过 Caco-2 单层的免疫染色和共焦成像来测量。

结果

在 13 种衍生物中,有两种使荧光标记物 calcein 的通透性增强了 100 多倍。发现苯环上的羟基或伯胺取代会显著增加毒性,而脂肪族取代则会导致与 1-苯基哌嗪相当的功效和毒性特征。

结论

几种有效的衍生物,包括 1-甲基-4-苯基哌嗪和 1-(4-甲基苯基)哌嗪,显示出比 1-苯基哌嗪更低的毒性,这表明在未来的应用中具有很大的潜力。

相似文献

1
Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.苯哌嗪衍生物作为肠道渗透增强剂的结构-功能分析。
Pharm Res. 2017 Jun;34(6):1320-1329. doi: 10.1007/s11095-017-2149-8. Epub 2017 Apr 3.
2
The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.哌嗪衍生物溶液的pH值预示着它们作为跨上皮渗透促进剂的效用。
Mol Pharm. 2016 Feb 1;13(2):578-85. doi: 10.1021/acs.molpharmaceut.5b00803. Epub 2016 Jan 13.
3
Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.哌嗪衍生物作为肠道渗透促进剂在离体大鼠肠黏膜中的研究。
AAPS J. 2020 Jan 27;22(2):33. doi: 10.1208/s12248-020-0416-9.
4
ATRP-grown protein-polymer conjugates containing phenylpiperazine selectively enhance transepithelial protein transport.原子转移自由基聚合生长的含苯哌嗪的蛋白-聚合物缀合物选择性增强跨上皮蛋白转运。
J Control Release. 2017 Jun 10;255:270-278. doi: 10.1016/j.jconrel.2017.04.035. Epub 2017 Apr 25.
5
Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.肠道渗透促进剂能够实现大小达70 kDa的大分子的口服递送。
Eur J Pharm Biopharm. 2022 Jan;170:70-76. doi: 10.1016/j.ejpb.2021.11.010. Epub 2021 Dec 5.
6
Piperazine Derivatives Enhance Epithelial Cell Monolayer Permeability by Increased Cell Force Generation and Loss of Cadherin Structures.哌嗪衍生物通过增加细胞力的产生和丧失细胞间黏附结构来增强上皮细胞单层通透性。
ACS Biomater Sci Eng. 2020 Jan 13;6(1):367-374. doi: 10.1021/acsbiomaterials.9b01660. Epub 2019 Dec 13.
7
A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.一种同时向肠道黏膜递送大分子和渗透促进剂的黏膜黏附型纳米颗粒系统。
J Control Release. 2011 Jan 5;149(1):81-8. doi: 10.1016/j.jconrel.2010.02.001. Epub 2010 Feb 6.
8
A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.一种用于增加治疗性大分子穿过肠的通透性的渗透增强剂。
J Control Release. 2013 Dec 10;172(2):541-9. doi: 10.1016/j.jconrel.2013.05.002. Epub 2013 May 14.
9
Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.开发一种非水分散体以改善低渗透性大分子的肠道上皮通量。
AAPS J. 2017 Jan;19(1):244-253. doi: 10.1208/s12248-016-9996-9. Epub 2016 Oct 13.
10
Effect of N-betainate and N-piperazine derivatives of chitosan on the paracellular transport of mannitol in Caco-2 cells.壳聚糖的 N-甜菜碱酯和 N-哌嗪衍生物对 Caco-2 细胞中甘露醇细胞旁转运的影响。
Eur J Pharm Sci. 2008 Oct 2;35(3):226-34. doi: 10.1016/j.ejps.2008.07.001. Epub 2008 Jul 15.

引用本文的文献

1
Nanostructure-Mediated Transport of Therapeutics through Epithelial Barriers.纳米结构介导的治疗药物经上皮屏障转运。
Int J Mol Sci. 2024 Jun 28;25(13):7098. doi: 10.3390/ijms25137098.
2
Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs.中大分子的口服吸收及其改善,重点关注新型药物
Pharmaceutics. 2023 Dec 28;16(1):47. doi: 10.3390/pharmaceutics16010047.
3
Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies.

本文引用的文献

1
An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.对渗透促进剂1-苯基哌嗪(PPZ)对大鼠肠黏膜在尤斯灌流小室中跨细胞旁通量影响的评估。
Pharm Res. 2016 Oct;33(10):2506-16. doi: 10.1007/s11095-016-1975-4. Epub 2016 Jul 7.
2
Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts.口服递药:近百年来的努力及现状。
Adv Drug Deliv Rev. 2016 Jun 1;101:108-121. doi: 10.1016/j.addr.2016.01.010. Epub 2016 Jan 27.
3
The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.
甜樱桃提取物作为酪氨酸激酶抑制剂的渗透促进剂:未来口服抗癌疗法的一个有前景的展望。
Pharmaceuticals (Basel). 2023 Oct 27;16(11):1527. doi: 10.3390/ph16111527.
4
Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery.突破壁垒:针对动态紧密连接的新型靶向方法以改善药物递送。
Adv Drug Deliv Rev. 2023 Aug;199:114905. doi: 10.1016/j.addr.2023.114905. Epub 2023 Jun 3.
5
Long-term daily oral administration of intestinal permeation enhancers is safe and effective in mice.长期每日口服肠道渗透促进剂对小鼠是安全有效的。
Bioeng Transl Med. 2022 May 31;8(1):e10342. doi: 10.1002/btm2.10342. eCollection 2023 Jan.
6
The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery.草莓来源的渗透增强剂锦葵色素可实现口服蛋白质递药。
Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2207829119. doi: 10.1073/pnas.2207829119. Epub 2022 Aug 9.
7
Oral delivery of peptide therapeutics in infants: Challenges and opportunities.婴儿经口递呈肽类治疗药物:挑战与机遇。
Adv Drug Deliv Rev. 2021 Jun;173:112-124. doi: 10.1016/j.addr.2021.03.011. Epub 2021 Mar 25.
8
Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.哌嗪衍生物作为肠道渗透促进剂在离体大鼠肠黏膜中的研究。
AAPS J. 2020 Jan 27;22(2):33. doi: 10.1208/s12248-020-0416-9.
9
Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability.阴离子纳米颗粒通过增强肠道通透性来实现蛋白质的口服递送。
Nat Biomed Eng. 2020 Jan;4(1):84-96. doi: 10.1038/s41551-019-0465-5. Epub 2019 Nov 4.
10
Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments.利用 Caco-2 肠上皮细胞构建经济型快速肠单层(TRIM)用于口服药物传递实验。
Pharm Res. 2019 Oct 28;36(12):172. doi: 10.1007/s11095-019-2712-6.
哌嗪衍生物溶液的pH值预示着它们作为跨上皮渗透促进剂的效用。
Mol Pharm. 2016 Feb 1;13(2):578-85. doi: 10.1021/acs.molpharmaceut.5b00803. Epub 2016 Jan 13.
4
Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents.哌嗪支架:生成多种药理活性剂的卓越工具。
Eur J Med Chem. 2015 Sep 18;102:487-529. doi: 10.1016/j.ejmech.2015.07.026. Epub 2015 Jul 18.
5
TEER measurement techniques for in vitro barrier model systems.体外屏障模型系统的跨上皮电阻测量技术。
J Lab Autom. 2015 Apr;20(2):107-26. doi: 10.1177/2211068214561025. Epub 2015 Jan 13.
6
Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.新生儿 fc 受体介导的 Fc 靶向纳米颗粒经肠道上皮细胞转运用于口服给药。
Sci Transl Med. 2013 Nov 27;5(213):213ra167. doi: 10.1126/scitranslmed.3007049.
7
Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.用于口服递送降钙素的黏膜黏附性肠道装置。
J Control Release. 2013 Dec 28;172(3):753-62. doi: 10.1016/j.jconrel.2013.09.004. Epub 2013 Sep 11.
8
Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates.树状聚合物-酶缀合物的持续胃肠道活性。
Nat Chem. 2013 Jul;5(7):582-9. doi: 10.1038/nchem.1675. Epub 2013 Jun 9.
9
A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.一种用于增加治疗性大分子穿过肠的通透性的渗透增强剂。
J Control Release. 2013 Dec 10;172(2):541-9. doi: 10.1016/j.jconrel.2013.05.002. Epub 2013 May 14.
10
Regulation of intestinal epithelial permeability by tight junctions.紧密连接对肠道上皮通透性的调节。
Cell Mol Life Sci. 2013 Feb;70(4):631-59. doi: 10.1007/s00018-012-1070-x. Epub 2012 Jul 11.